QUAGLIA, Wilma
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 14.682
EU - Europa 7.232
AS - Asia 5.416
SA - Sud America 727
AF - Africa 93
Continente sconosciuto - Info sul continente non disponibili 47
OC - Oceania 41
Totale 28.238
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 14.181
CN - Cina 2.562
RU - Federazione Russa 1.816
SG - Singapore 1.477
DE - Germania 1.327
IT - Italia 1.320
BR - Brasile 617
HK - Hong Kong 472
UA - Ucraina 467
SE - Svezia 457
CA - Canada 426
GB - Regno Unito 410
PL - Polonia 371
FI - Finlandia 362
FR - Francia 231
TR - Turchia 195
KR - Corea 174
VN - Vietnam 167
IE - Irlanda 124
IN - India 102
CZ - Repubblica Ceca 85
JP - Giappone 60
BE - Belgio 58
MX - Messico 53
NL - Olanda 52
EU - Europa 45
AR - Argentina 41
AU - Australia 38
ZA - Sudafrica 38
IR - Iran 31
ES - Italia 29
BD - Bangladesh 28
PK - Pakistan 26
EG - Egitto 23
EC - Ecuador 21
IQ - Iraq 20
LT - Lituania 19
RO - Romania 16
AT - Austria 15
AE - Emirati Arabi Uniti 13
HR - Croazia 13
PE - Perù 13
ID - Indonesia 10
UY - Uruguay 10
CO - Colombia 9
GR - Grecia 9
MA - Marocco 9
PT - Portogallo 9
CH - Svizzera 7
RS - Serbia 7
SA - Arabia Saudita 7
VE - Venezuela 7
AZ - Azerbaigian 6
CL - Cile 6
JO - Giordania 6
PH - Filippine 6
BY - Bielorussia 5
DZ - Algeria 5
IL - Israele 5
JM - Giamaica 5
KE - Kenya 5
KG - Kirghizistan 5
KH - Cambogia 5
MY - Malesia 5
PA - Panama 5
UZ - Uzbekistan 5
AL - Albania 4
LV - Lettonia 4
PS - Palestinian Territory 4
TH - Thailandia 4
TW - Taiwan 4
BG - Bulgaria 3
HU - Ungheria 3
IS - Islanda 3
KZ - Kazakistan 3
NP - Nepal 3
PY - Paraguay 3
QA - Qatar 3
SN - Senegal 3
A2 - ???statistics.table.value.countryCode.A2??? 2
DK - Danimarca 2
DO - Repubblica Dominicana 2
GA - Gabon 2
GH - Ghana 2
HN - Honduras 2
NI - Nicaragua 2
NO - Norvegia 2
NZ - Nuova Zelanda 2
TN - Tunisia 2
TT - Trinidad e Tobago 2
AD - Andorra 1
AM - Armenia 1
AO - Angola 1
BZ - Belize 1
CR - Costa Rica 1
CY - Cipro 1
EE - Estonia 1
ET - Etiopia 1
GE - Georgia 1
GT - Guatemala 1
Totale 28.229
Salva come PNG Salva come JPEG
Città #
Dallas 1.329
Woodbridge 1.178
Jacksonville 1.136
Fairfield 1.048
Ashburn 1.045
Chandler 879
Ann Arbor 682
Houston 659
Singapore 644
Wilmington 604
Boardman 488
Hong Kong 463
Seattle 439
Beijing 415
Nanjing 380
Cambridge 321
Toronto 282
Camerino 271
Los Angeles 266
Dearborn 242
Warsaw 223
New York 187
Düsseldorf 186
The Dalles 181
San Mateo 178
Seoul 170
Tongling 166
Lawrence 157
Princeton 157
Helsinki 153
Istanbul 141
Columbus 140
Nanchang 140
Kraków 138
Munich 134
Moscow 132
Dublin 124
Ogden 119
Buffalo 114
London 101
Kunming 98
Shanghai 98
Lachine 92
Shenyang 87
Milan 86
Guangzhou 67
Jiaxing 66
São Paulo 65
Brno 63
Tianjin 63
Turku 61
Brussels 56
Chicago 55
Hebei 54
Jinan 54
Ho Chi Minh City 53
Venezia 51
San Diego 49
Santa Clara 49
Changsha 48
Tokyo 47
Hangzhou 42
Philadelphia 40
Hanoi 37
Redwood City 37
Zhengzhou 35
Brooklyn 34
Frankfurt am Main 34
Stockholm 34
Poplar 33
Chennai 32
Wuhan 32
Nürnberg 31
Rome 31
Washington 30
Bremen 29
Denver 27
Falls Church 27
Montreal 27
Hefei 26
Leawood 26
Ningbo 26
Orem 25
Venice 25
Boston 24
Johannesburg 24
Taizhou 24
Council Bluffs 23
Nuremberg 22
Phoenix 22
Orange 21
Redondo Beach 21
Verona 21
Atlanta 20
Olomouc 20
Ankara 19
Monmouth Junction 19
Old Bridge 19
Augusta 18
Centro 18
Totale 18.229
Salva come PNG Salva come JPEG
Nome #
1,4-Dioxane, a Suitable Scaffold for the Development of Novel M3 Muscarinic Receptor Antagonists 587
1,4-DIOXANE NUCLEUS AS A SUITABLE SCAFFOLD FOR NOVEL D2-LIKE RECEPTOR LIGANDS 582
1,4-Dioxane nucleus as a suitable scaffold in the building of ligands interacting with NMDA and σ1 receptors 524
1'-Benzyl-3,4-dihydrospiro[2H-1-benzothiopyran-2,4'-piperidine] (Spipethiane), a potent and highly selective sigma1 lingand 518
1,4-Dioxane ring as a promising template of novel 5-HT1A full agonists 517
The Versatile 2-Substituted Imidazoline Nucleus as a Structural Motif of Ligands Directed to the Serotonin 5-HT1A Receptor 308
1-[3-(4-Butylpiperidin-1-yl)propyl]-1,2,3,4-tetrahydroquinolin-2-one (77-LH-28-1) as a Model for the Rational Design of a Novel Class of Brain Penetrant Ligands with High Affinity and Selectivity for Dopamine D4 Receptor 305
Antagonism/Agonism modulation to build novel antihypertensives selectively triggering i1-imidazoline receptor activation 304
Hyperphagic effect of novel compounds with high affinity for imidazoline I2 binding sites 288
Novel Potent N-Methyl-d-aspartate (NMDA) Receptor Antagonists or σ1 Receptor Ligands Based on Properly Substituted 1,4-Dioxane Ring 284
A Novel Class of Dopamine D4 Receptor Ligands Bearing an Imidazoline Nucleus 274
Combined Interactions with I1-, I2-Imidazoline Binding Sites and α2-Adrenoceptors To Manage Opioid Addiction 262
Novel ligands rationally designed for characterizing I2-imidazoline binding sites nature and functions 244
Novel antitumor copper(ii) complexes designed to act through synergistic mechanisms of action, due to the presence of an NMDA receptor ligand and copper in the same chemical entity 240
33rd camerino-Cyprus Symposium - Receptor Chemistry: Reality and Vision 240
31st Camerino-Cyprus-Noordwijkerhout Symposium - Receptor Chemistry Skyline 240
Nano-medicine improving the bioavailability of small molecules for the prevention of neurodegenerative diseases 238
2-(2-Phenylcyclopropyl)imidazolines: Reversed Enantioselective Interaction at I1 and I2 Imidazoline Receptors 232
Investigation of the Role of Chirality in the Interaction with σ Receptors and Effect on Binge Eating Episode of a Potent σ1 Antagonist Analogue of Spipethiane 230
Favourable involvement of α2A-adrenoreceptor antagonism in the I₂-imidazoline binding sites-mediated morphine analgesia enhancement. 228
Receptor Ligands as Helping Hands to L-DOPA in the Treatment of Parkinson's Disease 224
The replacement of the 2-methoxy substituent of N-((6,6-diphenyl-1,4-dioxan-2-yl)methyl)-2-(2-methoxyphenoxy)ethan-1-amine improves the selectivity for 5-HT1A receptor over α1-adrenoceptor and D2-like receptor subtypes 220
Multitarget 1,4-Dioxane Compounds Combining Favorable D2-like and 5-HT1A Receptor Interactions with Potential for the Treatment of Parkinson's Disease or Schizophrenia 219
alpha(2)-Adrenoreceptors profile modulation. 2. Biphenyline analogues as tools for selective activation of the alpha2C-subtype 217
Discovery of Highly Selective Imidazoline Receptor Ligands 211
Mode of interaction of 1,4-dioxane agonists at the M2 and M3 muscarinic receptor orthosteric sites 209
Identification of 2-aminopyrimidine derivatives as inhibitors of the canonical Wnt signaling pathway 208
Imidazoline binding sites (IBS) profile modulation: Key role of the bridge in determining I1-IBS or I2-IBS selectivity within a series of 2-phenoxymethylimidazoline analogues 206
14th Camerino-Noordwijkerhout Symposium - Ongoing Progress in Receptor Chemistry 205
Structure-activity relationships in 1,4-benzodioxan-related compounds. Investigation on the role of the dehydrodioxane ring on alpha1-adrenoreceptor blocking activity 200
Role of the NMDA Receptor in the Antitumor Activity of Chiral 1,4-Dioxane Ligands in MCF-7 and SKBR3 Breast Cancer Cells 193
Novel 1,4-dioxane derivatives as NMDA receptor channel blockers 192
Structure-activity relationships in 1,4-benzodioxan-related compounds. 7. Selectivity of 4-phenylchroman analogues for alpha(1)-adrenoreceptor subtypes 191
Dopamine D-5 receptors: A challenge to medicinal chemists 191
Deoxamuscaroneoxime Devatives as useful Muscarinic Aginist to Explore the Muscarinic Subsite: Demox, Amodulator of Orthosteric and Allosteric Site at Cardiac Muscarinic M2 Receptors. 190
Structure-activity relationships among benextramine-related tetraamine disulfides at peripheral alpha-adrenoreceptors 190
Novel Highly Potent and Selective σ1 Receptor Antagonists Related to Spipethiane 189
3-Phenyl analogues of 2-[[[2-(2,6-Dimethoxyphenoxyethyllamino]methyl]-1,4-benzodioxan (WB 4101) as highly selective alpha1-adrenoreceptor antagonists1 189
33rd Camerino-Cyprus Symposium - Receptor Chemistry: Reality and Vision 189
Rapid novel divergent synthesis and muscarinic agonist profile of all four optical isomers of N,N,N-trimethyl(6-methyl-1,4-dioxan-2-yl)methanaminium iodide. 187
Chemical manipulations on the 1,4-dioxane ring of 5-HT1A receptor agonists lead to antagonists endowed with antitumor activity in prostate cancer cells 187
Muscarinic subtypes profile modulation within a series of new antagonists, bridged bicyclic derivatives of 2,2-diphenyl-[1,3]-dioxolan-4-ylmethyl-dimethylamine 186
Roles of Wnt/β-catenin signalling pathway in the bony repair of injured growth plate cartilage in young rats 183
31st Camerino-Cyprus-Noordwijkerhout Symposium - Receptor Chemistry Skyline 183
Synthesis and muscarinic properties of (1S*,3R*,5R*)-trimethyl(1-methyl-6-oxabicyclo[3.1.0]hex-3-yl)methyl ammonium iodide 183
Design, synthesis and muscarinic activity of deoxamuscarine-related derivatives 183
Homoazanicotine: A structure-affinity study for nicotinic acetylcholine (nACh) receptor binding 182
Use of frozen sections for the pharmacological characterization of compounds active on neurotransmitter receptors 182
77-LH-28-1 as a model for the rational design of selective dopamine D4 receptor ligands 182
Low doses of allyphenyline and cyclomethyline, effective against morphine dependence, elicit an antidepressant-like effect 181
Search for selective antagonists at alpha1-adrenoreceptors: neutral or negative antagonism? 181
Synthesis and cytotoxic activity evaluation of new Cu(I) complexes of bis(pyrazol-1-yl) acetate ligands functionalized with an NMDA receptor antagonist 180
Structure−Activity Relationships in 1,4-Benzodioxan-Related Compounds. 11.1 Reversed Enantioselectivity of 1,4-Dioxane Derivatives in α1‑Adrenergic and 5‑HT1A Receptor Binding Sites Recognition 179
28th Camerino-Cyprus-Noordwijkerhout Symposium - Trekking through Receptor Chemistry 177
Properly substituted 1,4-dioxane nucleus favours the selective M3 muscarinic receptor activation 176
Potent muscarinic antagonists bearing 1,4-dioxane scaffold 176
Synthesis and structure-activity relationships of cetiedil analogues as blockers of the Ca2+-activated K+ permeability of erythrocytes 174
Binding of nicotine and homoazanicotine analogues at neuronal nicotinic acetylcholinergic (nACh) receptors 174
Antimuscarinic activity in a series of 2-substituted 1,3-dioxolanes 172
Synthesis and Biological Evaluation of a Novel Series of Heterobivalent Muscarinic Ligands Based on Xanomeline and 1‑[3- (4-Butylpiperidin-1-yl)propyl]-1,2,3,4-tetrahydroquinolin-2-one (77- LH-28-1) 172
Alpha(2)-Adrenoreceptors Profile Modulation. 3. (R)-(+)-m-Nitrobiphenyline, a New Efficient and alpha(2C)-Subtype Selective Agonist. 171
Solution-phase synthesis of ICG-001, a beta-turn peptidomimetic molecule inhibitor of beta-catenin-Tcf-mediated transcription 170
16th Camerino-Noordwijkerhout Symposium - An Overview of Receptor Chemistry 170
Exploring multitarget interactions to reduce opiate withdrawal syndrome and psychiatric comorbidity 170
Synthesis and Structure-Activity Relationship Studies in a Series of 2-Substituted 1,3-Dioxolanes Modified at the Cationic Head. 170
Might Adrenergic alpha2C-agonists/alpha2A-antagonists become novel therapeutic tools for pain treatment with morphine? 170
4WD to Travel Inside the 5-HT1A Receptor World 169
Muscarinic Thioligands with Cyclopentane Nucleus 168
Rational design and biological evaluation of novel conjugated heteroscorpionate ligands and related Copper(I/II) complexes 168
Allyphenyline analogues potentially useful in the management of chronic pain and opioid addiction. 167
Dioxane and Oxathiane Nuclei: Suitable Substructures for Muscarinic Agonists 166
Structure-activity relationships in prazosin-related compounds. Effect of replacing a piperazine ring with an alkanediamine moiety on alpha1- adrenoreceptorblocking activity. 166
Chain-lengthened and imidazoline analogues of nicotine 165
Structure-activity relationships among benextramine-related tetraamine disulfides. Chain length effect on alpha-adrenoreceptor blocking activity1 165
Novel Potent 5-HT1a Agonists Selective over alpha1-Adrenoceptor Subtypes 165
Synthesis, Absolute Configuration, and Biological Profile of the Enantiomers of trans-[2-(2,6-Dimethoxypheoxy)ethyl] [(3-p-tolyl-2,3-dihydro-1,4-benzodioxin-2-yl)methyl]amine (Mephendioxan), a Potent Competitive alpha 1A-Adrenoreceptor Antagonist 164
Alpha(2)-adrenoreceptors profile modulation and high antinociceptive activity of (S)-(-)-2-[1-(biphenyl-2-yloxy)ethyl]-4,5-dihydro-1H-imidazole 164
null 162
Fruitful Adrenergic alpha(2C)-Agonism/alpha(2A)-Antagonism Combination to Prevent and Contrast Morphine Tolerance and Dependence 159
Ligand binding to I2 imidazoline receptor: the role of lipophilicity in quantitative structure-activity relationship models 158
Novel highly potent and selective sigma1 receptor antagonists effectively block the binge eating episode in female rats 158
Structure-activity relationships in 1,4-benzodioxan-related compounds. 8.(1) {2-[2-(4 chlorobenzyloxy)phenoxy]ethyl}-[2-(2,6-dimethoxyphenoxy)ethyl]amine (clopenphendioxan) as a tool to highlight the involvement of alpha1D- and alpha1B-adrenoreceptor subtypes in the regulation of human PC-3 prostate cancer cell apoptosis and proliferation 158
Differential blockade of muscarinic receptor subtypes by polymethylene tetraamines. Novel class of selective antagonists of cardiac M-2 muscarinic receptors 157
The 2-substituted imidazoline ring linked to an aromatic moiety by a biatomic bridge: a bioversatile scaffold 157
Novel muscarinic acetylcholine receptor hybrid ligands embedding quinuclidine and 1,4-dioxane fragments 156
alpha(2)-adrenoreceptors profile modulation. 4. From antagonist, to agonist behavior 155
DOPAMINE D2, D3, AND D4 RECEPTOR AFFINITIES OF 77-LH-28-1 AND ITS ANALOGUES 155
TESTING D2-LIKE RECEPTOR AFFINITY AND SELECTIVITY WITH NOVEL IMIDAZOLINE DERIVATIVES 154
Enantioselective interactions to improve adrenergic α2C-agonism/α2A-antagonism 153
NOVEL BIVALENT LIGANDS OF XANOMELINE AND 77-LH-28-1 AS POTENTIAL M1 MUSCARINIC AGONISTS 153
Imidazoline receptors: Qualitative structure-activity relationships and discovery of tracizoline and benazoline. Two ligands with high affinity and unprecedented selectivity 152
Rational design of novel I1-imidazoline receptor agonists 150
Might adrenergic α2C-agonist/α2A-antagonist become a novel therapeutic multitarget tool for morphine chronic treatment of pain? 150
I1 imidazoline receptor-mediated effects on apoptotic processes in PC12 cells. 149
From benzodioxane to 1,4-dioxane scaffold in the design of 5-HT1A serotoninergic full agonists from α1-adrenergic antagonists 148
I recettori adrenergici 148
Pharmacophore development and 3D-QSAR study of I1 imidazoline binding site ligands 146
Alpha 1-adrenoreceptor antagonists bearing a quinazoline or a benzodioxane moiety 145
Adrenoceptors as targets in drug discovery: Medicinal chemistry and therapeutical potential 143
Byciclic dioxolanes as potential antimuscarinic agents 143
Totale 20.615
Salva come PNG Salva come JPEG
Categoria #
all - tutte 113.128
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 113.128
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.751 0 0 0 0 0 163 367 80 233 128 515 265
2021/20221.729 135 408 28 117 134 88 47 119 134 198 119 202
2022/20232.361 284 70 117 328 268 315 17 137 429 130 170 96
2023/20241.698 221 100 128 57 70 151 74 48 183 68 42 556
2024/20255.708 259 127 465 263 176 324 657 1.348 443 364 382 900
2025/20265.261 549 613 1.680 1.310 974 135 0 0 0 0 0 0
Totale 28.667